Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed250%

unknown125%

active_not_recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

active_not_recruiting

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

NCT05776225

completednot_applicable

Pulmonary Artery Pressure in COVID-19 Survivors

NCT05993338

unknown

RUS-registry of PH

NCT03707561

completed

Correlation of Physical Exam Versus Non-invasive Assessment Versus Invasive Assessment of Central Venous Pressure

NCT01574690

Clinical Trials (4)

Showing 4 of 4 trials

NCT05776225

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

Active Not Recruiting

NCT05993338Not Applicable

Pulmonary Artery Pressure in COVID-19 Survivors

RUS-registry of PH

Correlation of Physical Exam Versus Non-invasive Assessment Versus Invasive Assessment of Central Venous Pressure

Completed

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4